These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 11762936)

  • 1. Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile.
    Hurt-Camejo E; Paredes S; Masana L; Camejo G; Sartipy P; Rosengren B; Pedreno J; Vallve JC; Benito P; Wiklund O
    Arthritis Rheum; 2001 Dec; 44(12):2761-7. PubMed ID: 11762936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.
    Yoo WH
    J Rheumatol; 2004 Sep; 31(9):1746-53. PubMed ID: 15338494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase A2 and small, dense low-density lipoprotein.
    Hurt-Camejo E; Camejo G; Sartipy P
    Curr Opin Lipidol; 2000 Oct; 11(5):465-71. PubMed ID: 11048889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study.
    März W; Scharnagl H; Winkler K; Tiran A; Nauck M; Boehm BO; Winkelmann BR
    Circulation; 2004 Nov; 110(19):3068-74. PubMed ID: 15505088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant vitamins and lipid peroxidation in patients with rheumatoid arthritis: association with inflammatory markers.
    Paredes S; Girona J; Hurt-Camejo E; Vallvé JC; Olivé S; Heras M; Benito P; Masana L
    J Rheumatol; 2002 Nov; 29(11):2271-7. PubMed ID: 12415581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis.
    Rizzo M; Spinas GA; Cesur M; Ozbalkan Z; Rini GB; Berneis K
    Atherosclerosis; 2009 Dec; 207(2):502-6. PubMed ID: 19643412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
    Gabay C; McInnes IB; Kavanaugh A; Tuckwell K; Klearman M; Pulley J; Sattar N
    Ann Rheum Dis; 2016 Oct; 75(10):1806-12. PubMed ID: 26613768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up.
    Hartford M; Wiklund O; Mattsson Hultén L; Perers E; Person A; Herlitz J; Hurt-Camejo E; Karlsson T; Caidahl K
    Int J Cardiol; 2006 Mar; 108(1):55-62. PubMed ID: 16516698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in oxidized low-density lipoprotein and other inflammatory and adhesion molecules with a concomitant decrease in high-density lipoprotein in the individuals exposed to arsenic in Bangladesh.
    Karim MR; Rahman M; Islam K; Mamun AA; Hossain S; Hossain E; Aziz A; Yeasmin F; Agarwal S; Hossain MI; Saud ZA; Nikkon F; Hossain M; Mandal A; Jenkins RO; Haris PI; Miyataka H; Himeno S; Hossain K
    Toxicol Sci; 2013 Sep; 135(1):17-25. PubMed ID: 23761297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.
    Bolton CH; Downs LG; Victory JG; Dwight JF; Tomson CR; Mackness MI; Pinkney JH
    Nephrol Dial Transplant; 2001 Jun; 16(6):1189-97. PubMed ID: 11390719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
    Ridker PM; Stampfer MJ; Rifai N
    JAMA; 2001 May; 285(19):2481-5. PubMed ID: 11368701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma kinetics of an LDL-like non-protein nanoemulsion and transfer of lipids to high-density lipoprotein (HDL) in patients with rheumatoid arthritis.
    Pozzi FS; Maranhão RC; Guedes LK; Borba EF; Laurindo IM; Bonfa E; Vinagre CG
    J Clin Lipidol; 2015; 9(1):72-80. PubMed ID: 25670363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral adipose tissue accumulation, secretory phospholipase A2-IIA and atherogenecity of LDL.
    Paradis ME; Hogue MO; Mauger JF; Couillard C; Couture P; Bergeron N; Lamarche B
    Int J Obes (Lond); 2006 Nov; 30(11):1615-22. PubMed ID: 16534517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic lipid profile and high sensitive C-reactive protein in patients with rheumatoid arthritis.
    Singh HV; Shrivastava AK; Raizada A; Singh SK; Pandey A; Singh N; Yadav D; Sharma H
    Clin Biochem; 2013 Aug; 46(12):1007-1012. PubMed ID: 23578742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.
    Rodríguez-Carrio J; Alperi-López M; López P; López-Mejías R; Alonso-Castro S; Abal F; Ballina-García FJ; González-Gay MÁ; Suárez A
    J Clin Lipidol; 2017; 11(4):1043-1054.e2. PubMed ID: 28662934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of atherogenic indices with C-reactive protein and risk factors to assess cardiovascular risk in rheumatoid arthritis patient at Tikur Anbessa Specialized Hospital, Addis Ababa.
    Dessie G
    PLoS One; 2022; 17(6):e0269431. PubMed ID: 35657933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis.
    Vallvé JC; Paredes S; Girona J; Uliaque K; Ribalta J; Hurt-Camejo E; Masana L
    J Rheumatol; 2008 Sep; 35(9):1697-703. PubMed ID: 18634161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does a lack of physical activity explain the rheumatoid arthritis lipid profile?
    AbouAssi H; Connelly MA; Bateman LA; Tune KN; Huebner JL; Kraus VB; Winegar DA; Otvos JD; Kraus WE; Huffman KM
    Lipids Health Dis; 2017 Feb; 16(1):39. PubMed ID: 28187765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.